Myasthenia Gravis

MYASTHENIA GRAVIS

Overview

  • Chronic autoimmune disorder characterized by muscle weakness.
  • Improves with rest.

Pathophysiology

  • Antibodies destroy acetylcholine (ACh) receptors.
  • Loss of voluntary muscle strength due to inability of ACh to stimulate muscle contraction.

Etiology

  • Unknown causes; potential associations include autoimmune mechanisms and thymus disorders.
  • Possible viral origin.
  • More common in women aged 30-39 and men over 60.
  • Two types: Ocular and generalized.

Signs and Symptoms

  • Progressive muscle weakness, particularly with activity.
  • Common symptoms include:
    • Ptosis
    • Fatigue
    • Difficulty chewing, swallowing, speaking
    • Breathing difficulties
    • Mask-like facial expression
  • Symptoms show remissions and exacerbations.

Diagnostic Testing

  • Physical exam
  • Chest radiography
  • Electromyography (EMG)
  • Acetylcholine receptor antibody test (AChR)
  • Tensilon test (inject tension to assess worsening ptosis).

Medical Management

  • Thymectomy: Decreases AChR antibodies.
  • Anticholinergics: Neostigmine (Prostigmin), Pyridostigmine (Mestinon).
  • Immunosuppressants: Prednisone, Azathioprine (Imuran).
  • Plasmapheresis for severe respiratory distress.

Complications

  • Myasthenic Crisis: weakness leading to respiratory failure due to too little medication.
  • Cholinergic Crisis: symptoms include salivation, lacrimation, urinary incontinence, diarrhea due to too much medication (SLUDGE acronym).

Nursing Interventions

  • Fall prevention
  • Support ventilation and monitor respiratory status
  • Communication assistance
  • Medication administration and monitoring
  • Monitor for myasthenic or cholinergic crisis.

Patient Education

  • Avoid triggers for exacerbations:
    • Stress
    • Strenuous exercise
    • Infections
    • Temperature extremes
    • Electrolyte imbalances
  • Be cautious with medications that block neuromuscular junction actions.